Two Sigma Advisers’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-162,400
| Closed | -$8.52M | – | 513 |
|
|
2025
Q4 | $8.52M | Sell |
162,400
-410,572
| -72% | -$24.6M | 0.02% | 599 |
|
|
2025
Q3 | $37.1M | Sell |
572,972
-771,728
| -57% | -$44.3M | 0.07% | 215 |
|
|
2025
Q2 | $65.4M | Buy |
1,344,700
+547,500
| +69% | +$21.2M | 0.13% | 154 |
|
|
2025
Q1 | $27.1M | Buy |
797,200
+712,400
| +840% | +$30.2M | 0.06% | 279 |
|
|
2024
Q4 | $3.34M | Buy |
84,800
+28,400
| +50% | +$1.34M | 0.01% | 884 |
|
|
2024
Q3 | $2.65M | Buy |
+56,400
| New | +$2.86M | 0.01% | 944 |
|
|
2023
Q4 | – | Sell |
-9,600
| Closed | -$436K | – | 2525 |
|
|
2023
Q3 | $436K | Sell |
9,600
-7,700
| -45% | -$398K | ﹤0.01% | 1840 |
|
|
2023
Q2 | $971K | Buy |
+17,300
| New | +$982K | ﹤0.01% | 1548 |
|
|
2021
Q4 | – | Sell |
-220,600
| Closed | -$24.7M | – | 2658 |
|
|
2021
Q3 | $24.7M | Sell |
220,600
-684,200
| -76% | -$85.9M | 0.06% | 272 |
|
|
2021
Q2 | $146M | Sell |
904,800
-122,900
| -12% | -$14.9M | 0.39% | 62 |
|
|
2021
Q1 | $125M | Buy |
1,027,700
+668,000
| +186% | +$101M | 0.34% | 64 |
|
|
2020
Q4 | $55.1M | Buy |
359,700
+37,200
| +12% | +$4.4M | 0.15% | 150 |
|
|
2020
Q3 | $27M | Buy |
322,500
+88,800
| +38% | +$7.88M | 0.08% | 246 |
|
|
2020
Q2 | $17.2M | Buy |
233,700
+6,800
| +3% | +$398K | 0.05% | 366 |
|
|
2020
Q1 | $9.62M | Sell |
226,900
-60,800
| -21% | -$3.14M | 0.04% | 492 |
|
|
2019
Q4 | $17.5M | Buy |
287,700
+230,400
| +402% | +$12.6M | 0.04% | 423 |
|
|
2019
Q3 | $2.35M | Sell |
57,300
-54,800
| -49% | -$2.62M | 0.01% | 1051 |
|
|
2019
Q2 | $5.28M | Sell |
112,100
-127,300
| -53% | -$5.09M | 0.01% | 805 |
|
|
2019
Q1 | $8.55M | Sell |
239,400
-233,700
| -49% | -$8.08M | 0.02% | 660 |
|
|
2018
Q4 | $13.5M | Buy |
473,100
+60,000
| +15% | +$2.09M | 0.04% | 482 |
|
|
2018
Q3 | $18.3M | Buy |
413,100
+44,500
| +12% | +$2.33M | 0.04% | 414 |
|
|
2018
Q2 | $21.7M | Buy |
368,600
+334,200
| +972% | +$19M | 0.06% | 374 |
|
|
2018
Q1 | $1.57M | Buy |
+34,400
| New | +$1.42M | ﹤0.01% | 1352 |
|
Other funds holding CRSP
AIM
OAG
GP
SOCM
